Tag Archives: Allergan’s

Table for two: AbbVie was Allergan’s only suitor in $63B takeover that shocked the industry

AbbVie’s $ 63 billion, mega-takeover agreement for Allergan took most of the industry by surprise when the two drugmakers dropped the news in late June. Turns out it’s easier to keep a corporate courtship under wraps when only two parties are involved. The deal that turned into this year’s biggest M&A blockbuster began with a phone… Read More »